Clinical Trial Update: Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating the safety and efficacy of early combined therapy with PCSK9 inhibitors and statins in acute ischemic stroke, currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• PCSK9 inhibitors
• Statins

Snippet

Sponsor: Xiang Luo | Conditions: Acute Ischemic Stroke | Phase 2, Phase 3 | Status: RECRUITING